Literature DB >> 12594837

Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.

Eva Backström1, Benedict J Chambers, Emily L Ho, Olga V Naidenko, Raffaella Mariotti, Daved H Fremont, Wayne M Yokoyama, Krister Kristensson, Hans-Gustaf Ljunggren.   

Abstract

Natural killer cells have been reported to be able to kill various transformed and virus-infected target cells. It was recently observed that NK cells also could kill syngeneic dorsal root ganglia (DRG) neurons by a perforin-dependent mechanism. We demonstrate here that this phenomenon does not reflect a general ability of NK cells to kill neurons in culture. While DRG neurons of the peripheral nervous system were readily killed, ventral spinal cord neurons and hippocampal neurons of the central nervous system (CNS) were resistant to lysis. The resistance to NK cell-mediated lysis of the latter neurons was not related to protection by MHC class I molecules, since similar beta(2)-microglobulin(-/-) neurons were equally resistant to lysis. While exploring other possible molecular mechanisms for the selective triggering of lysis of DRG neurons, we observed that the retinoic acid early inducible gene-1 (RAE-1), the product of which is a ligand for the NK cell-activating receptor NKG2D, was expressed at high levels in the DRG neurons. In contrast, RAE-1 was expressed only at very low levels in the resistant CNS-derived neurons. Blocking NK cells withanti-NKG2D antibodies inhibited NK cell-mediated killing of the DRG neurons. Thus, we demonstrate that NK cell-mediated lysis of DRG neurons correlates with the expression of RAE-1 and that this lysis is dependent on activation of NK cells via NKG2D. This observation demonstrates that NK cells can kill non-pathogen-infected or non-transformed syngeneic cells through activation of the NKG2D receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594837     DOI: 10.1002/immu.200390012

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Perforin Promotes Amyloid Beta Internalisation in Neurons.

Authors:  Erica Lana; Mahbod Khanbolouki; Charline Degavre; Eva-Britt Samuelsson; Elisabet Åkesson; Bengt Winblad; Evren Alici; Christina Unger Lithner; Homira Behbahani
Journal:  Mol Neurobiol       Date:  2016-01-16       Impact factor: 5.590

Review 3.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

4.  Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.

Authors:  Ajai A Dandekar; Katherine O'Malley; Stanley Perlman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  The immunogenetics of multiple sclerosis: A comprehensive review.

Authors:  Jill A Hollenbach; Jorge R Oksenberg
Journal:  J Autoimmun       Date:  2015-07-02       Impact factor: 7.094

6.  Ischemic neurons recruit natural killer cells that accelerate brain infarction.

Authors:  Yan Gan; Qiang Liu; Wei Wu; Jun-Xiang Yin; Xue-Feng Bai; Rulong Shen; Yongjun Wang; Jieli Chen; Antonio La Cava; Jennifer Poursine-Laurent; Wayne Yokoyama; Fu-Dong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Authors:  Robert A Eagle; Insiya Jafferji; Alexander D Barrow
Journal:  Curr Immunol Rev       Date:  2009-02

8.  Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition.

Authors:  Anna Lünemann; Jan D Lünemann; Susanne Roberts; Brady Messmer; Rosa Barreira da Silva; Cedric S Raine; Christian Münz
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 9.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

10.  Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.

Authors:  Juan A García-León; Carlos López-Gómez; Teresa Orpez-Zafra; Virginia Reyes-Garrido; Carmen Marín-Bañasco; Begoña Oliver-Martos; Oscar Fernández; Laura Leyva
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.